Portal de Periódicos da CAPES

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

2015; Elsevier BV; Volume: 126; Issue: 8 Linguagem: Inglês

10.1182/blood-2015-04-639831

1528-0020

Stefan O. Ciurea, Mei-Jie Zhang, Andrea A. Bacigalupo, Asad Bashey, Frederick R. Appelbaum, Omar S. Aljitawi, Philippe Armand, Joseph H. Antin, Junfang Chen, Steven M. Devine, Daniel H. Fowler, Leo Luznik, Ryotaro Nakamura, Paul V. O’Donnell, Miguel‐Angel Perales, Sai Ravi Pingali, David Porter, Marcie R. Riches, Olle Ringdén, Vanderson Rocha, Ravi Vij, Daniel J. Weisdorf, Richard E. Champlin, Mary M. Horowitz, Ephraim J. Fuchs, Mary Eapen,

Acute Lymphoblastic Leukemia research

Key Points Lower GVHD after haploidentical transplant with posttransplant cyclophosphamide compared with HLA-matched unrelated donor transplant. Comparable overall survival after haploidentical compared with matched unrelated donor transplant for AML.